Name:Yi-Ping Wu

Dean of Department of Aesthetic Plastic, TJH;
Chief Physician & Professor;
2009  Vice Chairman, China Institute of traditional Chinese and Western medicine medical cosmetology committee;
2006  Vice Chairman, Chinese Medical Association Hubei province and Wuhan City branch of the professional committee of plastic and cosmetic surgery.

Educational Background

1998-2002  NIDDK, NIH, USA           Postdoctral fellow
1988-1993  Tongji Medical University    Ph.D.
1981-1986  Tongji MedicalUniversity     M.D.


1. Breast cancer modified breast-conserving therapy and breast reconstruction after breast cancer operation;
2. The surgical treatment of obesity.


1. Wu Y, Karas M,Dupont J, Zhao H, Toyoshima Y and Le Roith, D.  Multiple signaling pathways are involved in the regulation IGF-I receptor inhibition of PTEN-enhanced apoptosis. Growth Horm IGF Res. 2004 ;14(1): 52-8.
2. Wu Y, Cui K,  Miyoshi K,  Hennighausen L, Green JE, Setser J,  Leroith D and Yakar S. Reduced circulating IGF-I levels delay the onset of chemically and genetically induced mammary tumors. Cancer Res 2003; 63: 4384-4388.
3. Wu Y, Yakar S, Zhao L, Hennighausen L, and Le Roith D. Circulation insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res. 2002 ;62:1030-1035. 
4. Yakar S, Rosen C.J, Beamer W G,  Acker-Bicknell C L, Wu Y, Liu J, Ooi GT,Setser J, Frystyk J, Biosclair Y R, and LeRoith D. Circulating levels of IGF-1 directly regulate bone growth and density   J. Clin. Invest. 110(6). Sept., 2002 771-781.                                                                 
5. Yakar S, Wu Y, Setser J, and Rosen Clifford J.  The role of circulating IGF-I: Lessons from human and animal models. Endocrine 19(3) Dec., 2002  239-248.
6. Yakar, S, Liu J, Fernandez AM, Wu Y, Schally AV, Frystyk J, Chernausek SD, Mejia W,  and Le Roith D. Liver- specific IGF-1 gene deletion leads to muscle insulin insensitivity. Diabetes. 2001; 50: 1110-1118.
7. LeRoith D., Karas M, Yakar S, Wu Y, Qu B, and Blakesley VA  The role of the insulin-like growth factors in cancer. IMAJ  1999 ; 1: 25-30.

Professional Experience:
2010, Nov.-Dec.       Visitor,UMass Memorial Medical Center, Massachusetts, USA
2006, Dec.-present    Chief  Prof., Dept. Plastic Surgery, Tongji Hospital
2008, Sep.-Oct.         Visitor,the United States Pittsburgh Medical Center
2006, Mar.                 Visitor, MD Anderson Cancer Center, Univ. of Texas, Houston
2003-present              Professor  Dept. of  Surgery  Tongji Hospital
2002-2003                 Associate Professor, Dept. of Surgery, Tongji Hospital
1998-2002                 Postdoctral fellow, Clinical Endocrinology Branch, National Institutes of Diabetes and Digestive and Kidney Disease (NIDDK), National Institutes of Health, USA 
1996-1998                 Associate Professor, Dept. of Surgery, Tongji Hospital
1993-1996                 Attending Doctor, Dept. of Surgery, Tongji Hospital
1988-1993                 Postgraduate, Tongji Medical University
1986-1988                 Resident, Dept. of Surgery, Tongji Hospital